EXPRESSION OF LEPTIN IN BREAST CANCER PATIENTS
Abstract
in blood serum and tumor tissue of 58 patients of
reproductive age with different clinical characteristics of
breast cancer (BC) has been made. It was found by ELISA,
that LEP level in patients with rapid malignant tumor
growth is higher than in ones with mammary fibroadenoma
or in donor sera. The correlation between LEP andLEPR
gene expression was revealed by RT PCR and immunohistochemical
tissue staining in malignant mammary tumors
and triple negative BC. The data obtained have shown the
possible association between high LEP sera level and tumor
progression.
About the Authors
Е. ПередерееваRussian Federation
С. Клунова
Russian Federation
А. Параконная
Russian Federation
А. Фрыкин
Russian Federation
References
1. Girsouard J., Dembinski K., Mayer D., Keller U., Muller B. Targeting AMP-activated protein kinase in adipocytes to modulate obesity-related adipokine production associated with insulin resistance and breast cancer cell proliferation // Dietol.Metab. Syndr. 2011. Vol.3. № 1. P. 16-23.
2. Grossmann M.E, Ray A., Nkhata K.J, Malakhov D.A Obesity and breast cancer: status of leptin and adiponectin in pathological processes // Cancer Metast.Rev. 2010. Sept. P. 125-128.
3. Gupta V., Jafar T., Gupta V. Association of TNF- promoter gene G-308A polymorphism with metabolic syndrome, insulin resistance, serum TNF- and leptin levels in Indian adult women // Cytokine. 2011. May 24. PMID: 21616679.
4. Hou W.K., Xu Y.X., Yu T. Adipocytokines and breast cancer risk // Сlin.Med.J. 2007. Vol. 120. № 18. P. 1592-1596.
5. Jarde T., Caldefie-Chezet F., Damez M. et al. Leptin and leptin receptor involvement in cancer development: a study on human primary breast cancercinoma // Oncol.Rep. 2008. Vol. 19. № 4. P. 905-911.